Page last updated: 2024-08-24

trovafloxacin and Lymphoma

trovafloxacin has been researched along with Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borlak, J; Reymann, S	1

Other Studies

1 other study(ies) available for trovafloxacin and Lymphoma

Article	Year
Topoisomerase II inhibition involves characteristic chromosomal expression patterns. BMC genomics, 2008, Jul-08, Volume: 9 Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Chlorodiphenyl (54% Chlorine); Chromosome Mapping; Chromosomes, Human; Chromosomes, Mammalian; Doxorubicin; Enzyme Inhibitors; Etoposide; Female; Fluoroquinolones; Gene Expression Regulation; Hepatocytes; Humans; Lymphocytes; Lymphoma; Mice; Mice, Transgenic; Naphthyridines; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins c-myc; Topoisomerase II Inhibitors; Transcription Factors; Transcription, Genetic	2008

Article

Year

Topoisomerase II inhibition involves characteristic chromosomal expression patterns.

BMC genomics, 2008, Jul-08, Volume: 9

Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Chlorodiphenyl (54% Chlorine); Chromosome Mapping; Chromosomes, Human; Chromosomes, Mammalian; Doxorubicin; Enzyme Inhibitors; Etoposide; Female; Fluoroquinolones; Gene Expression Regulation; Hepatocytes; Humans; Lymphocytes; Lymphoma; Mice; Mice, Transgenic; Naphthyridines; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins c-myc; Topoisomerase II Inhibitors; Transcription Factors; Transcription, Genetic

2008